|
Blanco-García RM, López-Álvarez MR, Garrido IP, Salgado-Cecilia G, Campillo JA, Bolarín JM, Gimeno L, Muro M, García-Alonso AM, Martínez-Sánchez MV, Bernardo Pisa MV, Soriano-Díaz S, Pascual-Figal DA, Alvarez-López MR, Minguela A. Post-transplant increase in soluble human leukocyte antigen-G associated with non-severe cardiac allograft vasculopathy. Hum Immunol. 2013 Mar;74(3):318-24. doi: 10.1016/j.humimm.2012.12.001. PubMed PMID: 23247208.
AÑO: 2013; IF: 2.282
|
23247208
|
Asensio-López MC, Sánchez-Más J, Pascual-Figal DA, Abenza S, Pérez-Martínez MT, Valdés M, Lax A. Involvement of ferritin heavy chain in the preventive effect of metformin against doxorubicin-induced cardiotoxicity. Free Radic Biol Med. 2013 Apr;57:188-200. doi: 10.1016/j.freeradbiomed.2012.09.009. PubMed PMID: 23000260.
AÑO: 2013; IF: 5.71
|
|
Garrido IP, García-Lara J, Pinar E, Pastor-Pérez F, Sánchez-Mas J, Valdés-Chavarri M, Pascual-Figal DA. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy. Am J Cardiol. 2012 Sep 1;110(5):655-61. doi: 10.1016/j.amjcard.2012.04.047. Epub 2012 May 26. PubMed PMID: 22640973.
AÑO: 2012; IF: 3.209
|
|
Martínez-Ruiz A, Tornel-Osorio PL, Sánchez-Más J, Pérez-Fornieles J, Vílchez JA, Martínez-Hernández P, Pascual-Figal DA. Soluble TNF? receptor type I and hepcidin as determinants of development of anemia in the long-term follow-up of heart failure patients. Clin Biochem. 2012 Nov;45(16-17):1455-8. doi: 10.1016/j.clinbiochem.2012.05.011. Epub 2012 May 17. PubMed PMID: 22609894.
AÑO: 2012; IF: 2.45
|
|
Asensio-Lopez MC, Sanchez-Mas J, Pascual-Figal DA, de Torre C, Valdes M, Lax A. Ferritin heavy chain as main mediator of preventive effect of metformin against mitochondrial damage induced by doxorubicin in cardiomyocytes. Free Radic Biol Med. 2014 Feb;67:19-29. doi: 10.1016/j.freeradbiomed.2013.11.003. PubMed PMID: 24231192.
AÑO: 2014; IF: 5.736
|